KINSHASA, Democratic Republic of the Congo / RankWire.AI / – In Kisangani, the capital of Tshopo Province, health authorities in the Democratic Republic of the Congo have initiated a focused Ebola vaccination drive to fight the nation’s most severe outbreak to date. Frontline healthcare workers, emergency response teams, and individuals with direct exposure to confirmed cases are being prioritized during the initial phase of the deployment. Health Minister Roger Kamba announced that the government launched the immunization effort using doses of the Ervebo vaccine to protect frontline personnel working in the affected eastern regions.
Official data from epidemiological sources shows that the outbreak has now spread across six eastern provinces, which include Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Statistics from the Ministry of Public Health and Prevention indicate that the country has confirmed 5,713 cases and recorded 2,744 deaths. The current case fatality rate among confirmed cases is approximately 48%.
The outbreak emergency has prompted support from international health organizations, including the World Health Organization, to bolster local medical teams through logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while researchers gather observational data on its efficacy against the regional viral strain. DR Congo is advancing its Ebola vaccination campaign as health workers ramp up ring vaccination strategies around identified infection clusters to break transmission chains.
DR Congo Implements Wide-Scale Ebola Vaccination in Eastern Provinces Affected by Outbreak
Operational challenges in logistics are arising due to regional infrastructure complexities, ongoing security issues, and high population movement across border districts. To maintain vaccine integrity, cold-chain supply systems have been established in Kisangani to preserve the ultra-low temperatures needed before distribution to remote health zones. As part of the response, DR Congo has launched Ebola vaccination efforts, with civil defense and community health workers conducting education campaigns to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working with local teams to monitor vaccine safety and assess immune responses among vaccinated populations. Officials stressed that early detection combined with isolation and supportive treatment remains crucial to improving survival rates. Additional vaccine consignments are scheduled for delivery as distribution expands to secondary health districts in the region.
Kisangani Acts as Central Hub for Regional Ebola Vaccine Distribution
Contact-tracing operations are being scaled up by national teams across urban and rural areas within the eastern territory. Local health facilities are receiving supplies such as personal protective equipment, diagnostic reagents, and therapeutic resources to enhance readiness. The government has reaffirmed that comprehensive public health measures will stay in place until viral transmission rates demonstrate consistent decline across all affected provinces.
Communities are being urged to cooperate fully with mobile vaccination teams and to follow established health guidelines. Public health agencies anticipate that increasing immunization coverage among high-risk groups will help stabilize infection rates over the upcoming weeks. Enhanced surveillance will continue at transportation hubs and border crossings to prevent further spread across regions.